The Galapagos share
Galapagos NV (ticker: GLPG) has been listed on Euronext Amsterdam and Brussels since 6 May 2005 and on the NASDAQ Global Select Market since 14 May 2015. Galapagos NV forms part of the Bel20 index (top 20 listed companies) on Euronext Brussels, the AEX Index (top 25 listed companies) on Euronext Amsterdam, and the NASDAQ Biotechnology Index on NASDAQ in New York.
The Galapagos share in 2017
In 2017, the average daily trading volume on Euronext was 426,756 shares and €31.8 million turnover. The daily trading volume on NASDAQ in 2017 was 147,322 ADSs and $12.4 million turnover.
Galapagos vs Next Biotech Index in 2017
Galapagos vs Nasdaq Biotechnology Index
Investor relations activities
We attracted additional sell-side analyst coverage by U.S. and European banks. Our IR team presented at a number of conferences in 2017 and did several of broker-organized and self-organized roadshows throughout the U.S. and Europe. We presented 2016 Full Year, and Q1, Half Year, and Q3 2017 results, the FLORA results, and our R&D Update via webcasts.
The main topics of discussion with investors included the filgotinib programs, our results with GLPG1690 in the FLORA Phase 2a trial in IPF patients and future plans with this fully proprietary asset, and progress toward developing a triple combination therapy for cystic fibrosis patients.